Short-term risks, long-term setups, and trade ideas for navigating market seasonalitySenior Market Analyst, Matthew Timpane CMT, recently went live on Timing Research's Analyze Your Trade show. While answering real-time questions and pulling charts to analyze, he unpacked S&P 500 levels, short-term market volatility, seasonal trends, and how options-related open interest levels can act as support/resistance. Below is the video, plus bullet points of the first five stocks he was given to analyze. ✅ Key Takea ...

SAN DIEGO, June 20, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired PepGen Inc. (NASDAQ:PEPG) securities between March 7, 2024 and March 3, 2025. PepGen is a clinical-stage biotechnology company that focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The Company's lead product candidate was PGN-EDO51, a proprietary enhanced delivery ...

Key Takeaways Investors turn to low-beta consumer staples like PM and KO amid market volatility and Fed rate pause. The Fed kept rates in the range of 4.25% to 4.5% and raised inflation forecasts due to tariff uncertainty. Stocks like NOMD, MO, and INGR offer strong earnings growth, dividend yields, and a favorable Zacks Rank.Geopolitical tensions, a delay in the interest rate cut and uncertainty over the impact of President Donald Trump’s tariffs have again made markets volatile. Although consumer confid ...

Key Takeaways NFG, PEGA and HEI each declared dividend increases, payable to shareholders on July 15. NFG offers a 2.41% yield with six hikes in five years; PEGA and HEI yield 0.12% and 0.07%, respectively. These dividend hikes come as investors seek stability amid rate uncertainty and geopolitical conflict.Volatility has returned to Wall Street as escalating geopolitical tensions and a delay in interest rate cuts continue to dent investors’ sentiment. Moreover, concerns over the impact of tariffs on the ...

SAN DIEGO, June 20, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) securities between February 7, 2025 and May 26, 2025. Rocket is a fully integrated, late-stage biotechnology company focused on the development of gene therapies, with direct on-target mechanism of action and clear clinical endpoints, for rare and devastating diseases.For more information, submit a form, ...

Today, on 20 June 2025, AS Inbank entered into a notarial merger agreement with its 100% subsidiary Inbank Ventures OÜ. As a result of the merger, Inbank Ventures OÜ will cease to exist without liquidation and AS Inbank will become its legal successor. Inbank Ventures OÜ is operating as a holding company and provides IT support services within the Inbank Group. The purpose of the merger is to align the Group’s legal structure with its actual business operations and to enhance organisational efficiency, whil ...

20 June 2025, 15:30 CET ArcelorMittal (“the company”) has today signed a sale and purchase agreement to sell its operations in Bosnia and Herzegovina. ArcelorMittal Zenica, an integrated steel plant, and ArcelorMittal Prijedor, an iron ore mining business which supplies the Zenica plant, will be sold to Pavgord Group. The company has made considerable investments and efforts to keep ArcelorMittal Zenica and ArcelorMittal Prijedor within the group. However, after a thorough strategic review, the company con ...

北京颐合中鸿律师事务所 二○二五年六月二十日 北京颐合中鸿律师事务所 关于申万宏源集团股份有限公司 2024 年度股东大会 法律意见书 北京颐合中鸿律师事务所 关于申万宏源集团股份有限公司 2024 年度股东大会 法律意见书 致：申万宏源集团股份有限公司 根据《中华人民共和国证券法》（以下简称"《证券法》"）、《中华人民 共和国公司法》（以下简称"《公司法》"）及中国证券监督管理委员会《上市 公司股东会规则》（以下简称"《股东会规则》"）等法律、行政法规和规范性 文件的规定及《申万宏源集团股份有限公司章程》(以下简称 "《公司章程》")的 有关规定，北京颐合中鸿律师事务所受申万宏源集团股份有限公司（以下简称 "公司"）委托，出具本法律意见书。 为出具本法律意见书，本所委派律师出席了公司本次股东大会，审查了公司 提供的关于召开本次股东大会的有关文件的原件和复印件，并对有关问题进行了 必要的核查和验证。公司已向本所保证和承诺：公司提供的文件和所作的陈述和 说明是完整的、真实的和有效的，且已向本所提供一切足以影响本法律意见书的 事实和文件，无任何隐瞒、疏漏之处。 本所律师同意将本法律意见书随公司本次股东大会决议一起 ...

Four-year data show preservation of cardiac function, including LVEFSkeletal muscle disease progression continues to slow with extended treatment (PUL v2.0)Deramiocel’s long-term safety profile remains favorableResults presented at PPMD’s 2025 Annual Conference SAN DIEGO, June 20, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, today announced positive four-year safety and efficacy results ...

6月20日，北京证券交易所（简称"北交所"）上市委员会今年第11次审议会议结果出炉，上海巴兰仕汽 车检测设备股份有限公司（简称"巴兰仕"）符合发行条件、上市条件和信息披露要求，成功过会。 上市委员会审议会议向巴兰仕提出问询的主要问题集中在业绩增长稳定性方面，包括要求其说明2023 年、2024年业绩增长的主要驱动因素，结合巴兰仕具体情况，说明可能影响其持续稳定增长的主要风险 因素及应对措施。 结合公司产品特性、境外市场中主要国内竞争对手情况等，补充说明公司产品在欧洲、亚洲、南美洲市 场的竞争优势，是否存在客户流失风险。结合境外客户的拓展与维护情况等，进一步说明境外客户的稳 定性。 今年1至6月，巴兰仕预计营业收入为5.13亿元至5.3亿元，较上年同期增长0.36%至3.68%；归属于母公 司所有者的净利润预计为7050万元至7400万元，较上年同期增长1.65%至6.70%；扣除非经常性损益后 归属于母公司股东的净利润为6800万元至7150万元，较上年同期增长0.44%至5.61%。 从北交所下发的审核问询函中可以发现，监管部门对于巴兰仕业绩增长的可持续性、销售增长稳定性以 及毛利率持续上升的合理性等多方面 ...